Succinate dehydrogenase and fumarate reductase from Escherichia coli  by Cecchini, Gary et al.
Review
Succinate dehydrogenase and fumarate reductase from Escherichia coli
Gary Cecchini a;b;*, Imke Schro«der c, Robert P. Gunsalus c, Elena Maklashina a;b
a Molecular Biology Division, VA Medical Center, San Francisco, CA 94121, USA
b Department of Biochemistry and Biophysics, University of California San Francisco, San Francisco, CA 94143, USA
c Department of Microbiology, Immunology, and Molecular Genetics, University of California, Los Angeles, CA 90095, USA
Received 18 May 2001; received in revised form 16 August 2001; accepted 12 October 2001
Abstract
Succinate-ubiquinone oxidoreductase (SQR) as part of the trichloroacetic acid cycle and menaquinol-fumarate
oxidoreductase (QFR) used for anaerobic respiration by Escherichia coli are structurally and functionally related
membrane-bound enzyme complexes. Each enzyme complex is composed of four distinct subunits. The recent solution of the
X-ray structure of QFR has provided new insights into the function of these enzymes. Both enzyme complexes contain a
catalytic domain composed of a subunit with a covalently bound flavin cofactor, the dicarboxylate binding site, and an iron^
sulfur subunit which contains three distinct iron^sulfur clusters. The catalytic domain is bound to the cytoplasmic membrane
by two hydrophobic membrane anchor subunits that also form the site(s) for interaction with quinones. The membrane
domain of E. coli SQR is also the site where the heme b556 is located. The structure and function of SQR and QFR are briefly
summarized in this communication and the similarities and differences in the membrane domain of the two enzymes are
discussed. ß 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
Many laboratories have contributed to our knowl-
edge of complex II over the past 50 years and this
body of work has come from many sources, includ-
ing a wide variety of prokaryotes as well as eukary-
otes. Several comprehensive reviews on complex II
have been published during the past decade and the
reader is encouraged to peruse these for a more de-
tailed examination of the multitude of interesting
facets of this enzyme [1^4]. In this review we will
focus on the properties of Escherichia coli succi-
nate-ubiquinone oxidoreductase (SQR) and mena-
quinol-fumarate oxidoreductase (QFR) which have
proved to be two excellent models for the study of
complex II. Surprisingly, although E. coli has been a
pre-eminent model organism in research laboratories
for the past century, it has only been for the past 20
years that signi¢cant strides have been made in our
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Abbreviations: SQR, succinate-ubiquinone oxidoreductase;
QFR, menaquinol-fumarate oxidoreductase; carboxin, 5,6-dihy-
dro-2-methyl-1,4-oxathiin-3-carboxanilide; FAD, £avin adenine
dinucleotide; HQNO, 2-n-heptyl-4-hydroxyquinoline-N-oxide;
PCP, pentachlorophenol; Q1/MQ1 and Q2/MQ2, homologs of
ubiquinone/menaquinone having one or two isoprenoid units at
position 6 of the quinone ring, respectively; TTFA, 4,4,4-tri-
£uoro-1-(2-thienyl)-butane-1,3-dione
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understanding of complex II from this organism.
These advances have resulted from a combination
of molecular genetic, biochemical, and biophysical
approaches where the ease of working with E. coli
can be taken of full advantage.
The ability of whole cells of E. coli to reversibly
oxidize succinate to fumarate has been recognized for
more than 75 years [5]. Some three decades later it
was shown that puri¢ed preparations of mammalian
succinate dehydrogenase, in addition to catalyzing
succinate oxidation, are also capable of fumarate re-
duction [6]. Nevertheless, the kinetic properties of the
mammalian enzyme suggested that it was poised to
oxidize succinate rather than reduce fumarate in
vivo, whereas other studies showed that enzyme
preparations from obligate anaerobic bacteria cata-
lyzed fumarate reduction more e⁄ciently than succi-
nate oxidation [7]. Thus, the question arose of
whether or not facultative anaerobic bacteria such
as E. coli had evolved a single enzyme that could
e⁄ciently catalyze both fumarate reduction and suc-
cinate oxidation or if two distinct enzymes were
present. Hirsch et al. [8], some 38 years ago, using
classical genetic approaches helped resolve this ques-
tion. These workers used ethyl methanesulfonate mu-
tagenesis of an E. coli K12 strain to select mutants
that were defective in growth on succinate. Subse-
quent analysis showed there were two distinct en-
zymes catalyzing succinate oxidation and fumarate
reduction depending on whether E. coli was grown
aerobically or anaerobically on selective media. In
agreement with the earlier studies [6,7] the aerobi-
cally expressed succinate dehydrogenase was shown
to have a succinate-oxidizing to fumarate-reduction
activity ratio of 25:1 [8]. By contrast, the E. coli
fumarate reductase was found to be relatively more
able to catalyze succinate oxidation with a ratio of
fumarate reduction to succinate oxidation of only
1.5:1 [8].
Partially puri¢ed preparations of eukaryotic and
prokaryotic succinate dehydrogenases had been
available since the 1950s [6,7,9] the ¢rst characterized
preparations of E. coli succinate dehydrogenase and
fumarate reductase did not become available until
the 1970s [10^12]. Both enzymes were found in the
membrane fraction of cells, however, the initial pu-
ri¢cations resulted in isolation of a soluble two-sub-
unit form of the enzyme of about 100 kDa [10,12]. A
deoxycholate solubilized fraction of E. coli succinate
dehydrogenase of 150 kDa was also reported [11]
indicating that this was the intact complex. Isolation
of highly puri¢ed four-subunit QFR and SQR com-
plexes was ¢nally accomplished in the 1980s using a
combination of detergent extraction and anion and
hydrophobic chromatography [13^15].
An advantage of studying E. coli QFR and SQR is
that the enzymes can be overexpressed to high levels.
A 20-fold overproduction of QFR can be achieved in
E. coli cells harboring a QFR-encoding plasmid [16].
This ampli¢cation of QFR results in a signi¢cant
increase in the level of membrane-associated protein
and the formation of a tubular network within the
cell composed of the four-subunit QFR protein and
cardiolipin [16,17]. Although the major phospholip-
ids of E. coli are phosphatidyl ethanolamine and
phosphatidyl glycerol the increased levels of cardio-
lipin associated with QFR suggest that lipid biosyn-
thesis of this phospholipid is speci¢cally increased
along with the synthesis of QFR [18]. Even though
the membrane fraction becomes highly enriched in
QFR, the protein complex apparently does not dis-
place other membrane protein constituents and the
cells grow normally [16]. Similar results have been
obtained in E. coli transformed with SQR-encoding
plasmids. Both the formation of tubules and an in-
crease in membrane vesicle formation are observed
when SQR is expressed to high levels [19]. The am-
pli¢ed SQR and QFR membrane fraction and tu-
bules appear to contain enzyme that is fully func-
tional and contains all the redox cofactors present
in complex II. The very high levels of protein that
can be obtained from E. coli have proved quite use-
ful during puri¢cation and characterization of the
enzyme and make these enzymes one of the best
models for understanding the structure and function
of complex II.
Ha«gerha«ll [4] has grouped SQRs and QFRs from
di¡erent organisms into three functional classes,
based on their in vivo function and the particular
quinone substrate used by the enzyme. Using her
classi¢cation system E. coli and mammalian SQRs
are examples of type 1 enzymes, in that they use
ubiquinone as a substrate and are poised to oxidize
succinate in vivo. E. coli QFR is a type 2 enzyme
since it catalyzes oxidation of the lower potential
menaquinol and more readily reduces fumarate in
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vivo. Other classi¢cation schemes have been devel-
oped for SQRs and QFRs based on di¡erences in
the b heme composition [20,21], the membrane bind-
ing domain polypeptides [22], or their fumarate re-
duction activity [23]. However, in all of these classi-
¢cation schemes E. coli SQR is grouped with
mammalian SQR indicative of the high degree of
structural and functional similarity. Based on these
schemes and available structures of complex II evolu-
tionary models have been proposed. It is suggested
that the present day membrane-bound enzymes have
evolved from a soluble fumarate reductase that con-
tained non-covalently bound £avin adenine dinucleo-
tide (FAD) and was thus incapable of succinate ox-
idation [2,24]. Subsequently the enzyme acquired the
appropriate iron^sulfur clusters and became associ-
ated with the membrane through a core four-helix
bundle polypeptide(s) that spans the membrane and
provides site(s) for interactions with quinones. Ulti-
mately, as in the case of E. coli QFR and SQR, the
FAD cofactor became covalently attached to the en-
zyme to enable succinate oxidation.
2. Molecular genetics of expression of FRD and SDH
2.1. Gene identi¢cation and organization
The QFR and SQR enzymes of E. coli are encoded
by the frdABCD and sdhCDAB gene clusters located
at 94 min and at 17 min on the chromosome, respec-
tively [25,26]. At the start of the sdhCDAB gene clus-
ter, the sdhC and sdhD genes encode the two mem-
brane embedded polypeptides that interact with
ubiquinone, and anchor the catalytic domain at the
membrane surface. The following genes encode the
£avoprotein (sdhA) and iron^sulfur protein (sdhB)
subunits that catalyze succinate reduction to fuma-
rate. For QFR, the gene order di¡ers whereby the
catalytic (frdAB) and membrane anchor polypeptide
genes (frdCD) are reversed. The QFR and SQR cat-
alytic subunit genes are highly conserved and re£ect
the biochemical and structural similarity of the two
enzymes. It is thus not surprising that the ‘A’ and ‘B’
genes that specify the catalytic polypeptides in each
complex exhibit extensive homology with respect to
the primary and secondary amino acid sequences.
The ‘A’ and ‘B’ gene designations are nearly univer-
sally used in bacteria to name the two catalytic poly-
peptides. Gene and amino acid sequences for the ‘C’
and ‘D’ membrane anchor polypeptides of E. coli
QFR and SQR are poorly conserved. However,
each gene speci¢es for a polypeptide, having three
transmembrane-spanning K-helical regions (see be-
low). Discovery and subsequent genetic characteriza-
tions of the E. coli frd and sdh genes has been re-
viewed elsewhere [2,27,28].
Recent advances in bacterial genome sequencing
have revealed numerous members of the frd/sdh
gene family. As of early 2001, approximately 80
frdA/sdhA genes were deposited in various public
DNA/protein sequence repositories. Interestingly,
without prior knowledge of the physiological role
of a particular enzyme (i.e., that encoded by a ho-
mologous set of frd/sdh-like genes) in the metabolism
of a given bacterium, it is not yet possible to predict
whether the enzyme product functions as a QFR or
as a SQR enzyme in vivo! Many enteric bacteria
such as E. coli contain both membrane-bound en-
zymes due to their facultative metabolism. When mi-
crobes are either obligate aerobes or obligate anaer-
obes, the homologous genes are assumed to encode
an SQR or QFR, respectively. Genes encoding the
subunits of the catalytic domain, composed of the
£avoprotein and the iron^sulfur protein, are readily
predicted from the DNA sequences, albeit without
inference to catalytic parameters. The genes for the
membrane-spanning anchor polypeptides are identi-
¢ed due to their adjacency directly upstream or
downstream of the catalytic subunit genes. Finally,
the number of genes encoding the membrane anchor
polypeptides may be either two (as in the case of E.
coli frdCD and sdhCD) or one (as in the example of
Bacillus subtilis sdhC and Wolinella succinogenes frdC
[1^4]). When there are two anchor polypeptides, the
number of transmembrane-spanning helices per poly-
peptide is always three. When there is only one poly-
peptide, it contains ¢ve transmembrane-spanning el-
ements. Thus, some diversity exists among bacteria
with respect to the number and the order of genes
encoding the membrane associated polypeptides.
2.2. Promoter location and structure
The transcriptional regulation of the E. coli
frdABCD and sdhCDAB genes has been studied ex-
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tensively over the past 15 years as a model for under-
standing the control of bacterial QFR and SQR en-
zyme synthesis. The frdABCD and sdhCDAB gene
clusters each contain a single promoter that allows
for their coordinated expression in an operon unit.
The site of frdABCD transcription is located 93 bp
upstream of the ¢rst gene, frdA [29]. The sdhCDAB
operon is expressed from single promoter located 219
bp before the start of sdhC transcription [30,31].
Expression of the two operons in E. coli occurs
under quite di¡erent conditions and re£ects the phys-
iological roles of the two enzymes in cellular metab-
olism.
2.3. Control of gene expression
The physiological roles of the SQR and QFR com-
plexes are to provide for electron transport during
aerobic and anaerobic cell growth conditions, respec-
tively [1^4,32]. Thus, the transcription of the
frdABCD and sdhCDAB operons responds to envi-
ronmental as well as internal cell signals to modulate
gene expression to meet cellular needs for energy
and/or carbon intermediates. The regulation of each
operon is brie£y described below.
The frdABCD operon is optimally expressed dur-
ing anaerobic cell growth conditions [29]. This re-
£ects the role of the QFR enzyme in the terminal
step of anaerobic respiration with fumarate as an
electron acceptor. The anaerobic control is provided
by the anaerobic global regulator Fnr, that serves to
positively regulate frdABCD transcription (i.e., an
activator). When cells are shifted to anaerobic con-
ditions, Fnr becomes activated through the forma-
tion of a iron^sulfur (4Fe^4S) cluster that allows it
to dimerize [33,34]. It then binds to a 14 bp Fnr
recognition site centered approximately 41 nucleoti-
des before the start of frdA transcription [35]. Similar
Fnr activator sites are positioned at other Fnr-acti-
vated operons in E. coli [34,36].
Overriding the Fnr-dependent anaerobic control is
a second layer of transcriptional control that occurs
in response to the presence of nitrate in the cell en-
vironment [29,35]. This anaerobic respiratory sub-
strate suppresses frdABCD gene expression via the
Nar two-component regulatory system [37,38]. As
nitrate respiration provides a higher potential for
energy generation than does fumarate, the cell pre-
fers to respire using nitrate when oxygen is absent.
NarX and NarQ along with NarL and NarP form
this unusual two-component regulatory system that
regulates the expression of a number of genes in-
volved in anaerobic respiration and fermentation
[37^39]. NarX and NarQ are typical sensor transmit-
ter proteins that detect the presence of the two
anions, nitrate and nitrite. Nitrate is the superior
signal and functions at two to three orders of mag-
nitude lower concentration than does nitrite [40,41].
Signal reception results in ATP-dependent phosphor-
ylation of NarX and/or NarQ to give NarX-phos-
phate and NarQ-phosphate. Either sensor transmit-
ter can function independently to activate NarL to
give NarL-phosphate [42]. NarL-phosphate then
binds in the frd promoter region to suppress FRD
synthesis. The mechanism for the nitrate-dependent
control is by repression of frdABCD transcription.
Recognition and/or binding of RNA polymerase at
the frdA promoter is apparently prevented when
NarL-phosphate is bound [35,38].
Thus, when cells are growing anaerobically with
nitrate present, fermentation pathway carbon £ow
is suppressed, and anaerobic respiration is directed
to nitrate as the terminal electron acceptor. When
nitrate is absent, respiration can then occur with di-
methyl sulfoxide, trimethylamine N-oxide, or fuma-
rate as the electron acceptor [37,43]. The anaerobic
induction of frd expression is about 10^15-fold via
Fnr, while the nitrate repression is about 25-fold [35].
Finally, the addition of fumarate to glucose grown
cells results in a two-fold induction of frdABCD gene
expression via a distinct two-component regulatory
system called DcuR/DcuS [44]. This control element
also modulates the uptake and/or export of dicarbox-
ylates from the cell via speci¢c inducible membrane
transporter.
The sdhCDAB operon is optimally expressed dur-
ing aerobic cell growth [30,43]. This expression re-
£ects the role of the SQR enzyme in the trichloro-
acetic acid (TCA) cycle where it catalyzes the initial
step of aerobic respiration to oxygen with succinate
as an electron donor. Expression of the sdhCDAB
operon is lowered by about 10-fold when cells are
shifted to anaerobic growth with glucose as the car-
bon supply [30]. Under the latter condition, the cell
has an excess of reducing equivalents and cannot
deal with the production of additional NADH/
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FADH, or reduced quinones generated by the TCA
cycle. The negative control of sdh gene expression
occurs by a repression mechanism due to the binding
of the ArcA regulatory protein at the sdhC promoter
[31]. ArcA is in an inactive state during aerobic cell
growth and only when cells are shifted to anaerobic
conditions does ArcA become activated by ArcB.
These two proteins compose an anaerobic responsive
two-component regulatory system [45,46] distinct
from Nar. The environmental signal(s) that ArcB,
the sensor transmitter, responds to is unknown.
However, once ArcB detects the signal(s), it is phos-
phorylated in an ATP-dependent fashion and in
turn, phosphorylates ArcA to give ArcA-phosphate.
Of the four ArcA binding sites in the sdhA promoter
region, only ArcA site II appears to be essential for
the repression of sdhCDAB gene expression [31]. The
sdh operon is also catabolite controlled, presumably
by CRP/cAMP. Gene expression varies by 10-fold
when cells are grown aerobically with di¡erent car-
bon compounds [30].
2.4. Translational coupling
The translation of the genes on the frdABCD and
sdhCDAB mRNAs are most likely coupled although
this has not been experimentally tested. By this trans-
lationally coupled process, translation initiates at a
ribosome binding site (RBS) located upstream of a
given gene, and then extends downstream into the
following gene(s) without being released from the
mRNA. This readthrough process is often manda-
tory when the downstream gene(s) lack a recogniz-
able RBS [47,48]. This mechanism of translational
coupling thus provides a means to ensure that a mul-
ti-subunit containing enzyme complex contains one
molecule each of the newly synthesized polypeptide
(e.g., FrdA, FrdB, FrdC, and FrdD in the mature
QFR complex). Of the four genes in the frdABCD
operon, three physically overlap by 4 and 14 bp
(frdB/frdC/frdD) [49]. This overlap is typical of
some bacterial genes that are transcribed in a
coupled fashion [47]. Likewise, in the sdhCDAB op-
eron, the two membrane anchor sdhCD genes over-
lap by 4 bp [50]. The contribution of translational
coupling between sdhDA and between sdhAB is less
clear. Alternatively, ribosomes may reinitiate at
unique RBSs upstream of sdhA and sdhB as a means
to ensure equimolar amounts of the needed polypep-
tides.
2.5. Enzyme assembly and membrane localization
signals
Little is known about either the primary or sec-
ondary polypeptide sequence determinants that spec-
ify for the ordered assembly and insertion of the
QFR and SQR enzymes into the bacterial cytoplas-
mic membrane. From inspection of the gene order of
the frdABCD and sdhCDAB genes, it is apparent that
the catalytic or the membrane subunits may be syn-
thesized before the other (e.g., as the order of genes
are reversed in the respective operons). Studies have
been done on the assembly of the QFR holoenzyme
using a T7-promoter-conditional expression system
[51]. It was found that even though the gene order
is frdABCD, the FrdCD polypeptides ¢rst assemble
together in the membrane and provide a site for sub-
sequent attachment of the catalytic FrdAB subunits.
Similar studies have not been done with sdhCDAB,
however, there the gene order shows that the mem-
brane anchor polypeptides SdhCD are synthesized
before the catalytic subunits and thus once assembled
within the membrane would also provide attachment
sites for the catalytic subunits SdhAB.
3. Structure^function of QFR and SQR
3.1. Overview of E. coli QFR structure
Over the past 2 years there has been a wealth of
structural information that has become available for
our understanding of complex II. Structures for the
complete E. coli QFR complex [52], as well as, one
from W. succinogenes [53] have been described. In
addition to these membrane-bound structures, four
soluble homologs of the £avoprotein subunit of fu-
marate reductase have been described [54^57], thus
allowing a detailed comparison of the structure of
this subunit and the mechanism of catalysis by the
enzyme. These available structures have also resulted
in several insightful review articles discussing the cat-
alytic mechanism [20,58^61] and thus in this commu-
nication we will focus only on the structure of the E.
coli enzymes.
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The crystal structure of E. coli QFR shows two
complexes that are related by a two-fold axis that
are approximately parallel to the membrane normal
and these complexes associate through their trans-
membrane regions [52]. The crystal contacts are
mediated by two ordered detergent molecules of The-
sit (C12E9, polyoxyethylene(9)dodecyl ether). The
contact region between the fumarate reductase mol-
ecules is, however, relatively small (V325 Aî 2) and
there is no suggestion that the functional fumarate
reductase exists as a dimer in the cell. The QFR
monomer is approximately 70 Aî in diameter at its
widest point (the FrdAB catalytic domain) and the
molecule is 110 Aî in length. The overall structure of
E. coli QFR is consistent with what had been pro-
posed by numerous workers using biochemical and
molecular genetics methodologies (see [1^4] and
references therein) (Fig. 1). The structure clearly
shows two structurally distinct domains. A mem-
brane-extrinsic catalytic domain composed of the
FrdA £avoprotein subunit and the iron^sulfur pro-
tein domain (FrdB). Although an X-ray structure is
so far unavailable for any succinate dehydrogenase it
can be anticipated that the general structure of the
catalytic domain (SdhAB) will be similar to that seen
for FrdAB based on the high degree of sequence
similarity [49,50,62,63] and cofactor composition
[64] (Table 1). The transmembrane domain of E.
coli QFR (FrdCD) is organized around a central
four-helix bundle, with two additional helices outside
this central core. The four-helix bundle arrangement
for the FrdCD subunits is also consistent with a
general model for the transmembrane domain of
complex IIs that predates the X-ray structures [22].
A di¡erence between E. coli QFR and SQR is the
lack of a heme moiety in the former complex. The
crystal structure of the W. succinogenes QFR, which
contains two hemes, has both heme molecules ap-
proximately perpendicular to the membrane surface
[53,59]. Based on the structural models for complex
Fig. 1. Structure of E. coli menaquinol-fumarate oxidoreductase (PDB code 1FUM). The QFR monomer is shown. The £avoprotein
(FrdA) is colored lavender, the physiological inhibitor oxaloacetate (OAA), and the covalently bound FAD cofactor are shown in
gray. The iron^sulfur protein subunit (FrdB) is shown in yellow and the [2Fe^2S], [4Fe^4S], and [3Fe^4S], clusters are shown in black
and red. The membrane-spanning subunit FrdC is shown in red and FrdD is shown in cyan. The two menaquinone molecules, QP
and QD are shown in gray within the FrdC and FrdD helices.
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II anchor domains [4,22] and site-directed mutagen-
esis studies of the E. coli SQR heme binding domain
[65,66] the single E. coli b556 heme may reside in an
environment similar to that of the heme bp from W.
succinogenes on the cytoplasmic side of the mem-
brane and proximal to the [3Fe^4S] cluster of SQR.
3.2. Flavoprotein (FrdA) of E. coli QFR
The FrdA subunit contains two major domains.
The ¢rst is the FAD binding domain based on a
Rossmann-type fold which is further associated
with the FrdA subunit through a covalent bond be-
tween the £avin C8K methyl group and the NO atom
of the side chain of His44. This type of covalent
£avin linkage had ¢rst been experimentally demon-
strated in beef succinate dehydrogenase [67] and later
for QFR from W. succinogenes [68] and E. coli [69].
The reason the FAD is bound covalently in complex
II is still not completely understood, however, it is
apparent that the covalent linkage and protein envi-
ronment raise the redox potential of the £avin some
140^170 mV (Table 1) as compared to free FAD
(Em =3219 mV). This is in agreement with the ob-
servation that in soluble fumarate reductases which
contain a non-covalently bound FAD cofactor the
Em is much lower (3152 mV) [70] and the enzymes
are unable to oxidize succinate. Site-directed mutants
of E. coli QFR where His44 was replaced also con-
tain stoichiometric amounts of non-covalently bound
FAD and also lose the ability to oxidize succinate
[71]aresult also observed in Saccharomyces cerevisiae
succinate dehydrogenase [72]. This led to the sugges-
tion that evolution of the covalent £avin linkage was
a necessary requirement during the evolution of com-
plex II to raise the redox potential of the £avin with
the result that this class of enzymes could then func-
tion as a succino-oxidase [71]. The mechanism of
how £avins become covalently attached to complex
II is still not completely understood, however, it has
been proposed that attack by a nucleophilic amino
acid side chain on a quinone methide form of the
isoalloxazine ring at the 8K-carbon may result in co-
valent attachment of the £avin ([73], see [74] for gen-
eral review of this subject). In this regard, it has been
shown that £avinylation is stimulated in fumarate
reductase and succinate dehydrogenase by the pres-
ence of citric acid cycle intermediates, such as succi-
nate, fumarate, malate, and OAA, [75,76] all of
which may bind with di¡erent degrees of a⁄nity to
the dicarboxylate binding site of complex II. The
binding of substrate or inhibitor to the £avoprotein
subunit thus may induce a conformational change
that properly aligns the £avin and peptide backbone
of the protein to allow the covalent £avin bond to
form. The same £avin linkage is present in E. coli
SQR and the covalent linkage has been used to ad-
vantage by using [14C]ribo£avin to identify immuno-
reactive components of complex II [77].
The second major domain of the FrdA £avopro-
tein subunit is a capping domain which is a general
feature of the £avoprotein containing subunit of all
the structurally analyzed fumarate reductases and re-
lated £avoproteins [52^60]. The capping domain and
£avin domain are connected by a small hinge region
consisting of two L strands and the dicarboxylate
binding site is located at the interface of these two
domains. The hinge connecting these two domains
can bend by more than 30‡ [60] consistent with an
opening and closing of the active site region during
catalysis. It has been suggested that £avoenzymes
often have £exible domains that may have a role in
controlling access to the active site of the enzyme
[78].
Table 1
Midpoint potentials (mV) of the redox cofactors of E. coli QFR and SQRa
Enzyme FAD [2Fe^2S] [4Fe^4S] [3Fe^4S] Quinone (acceptor/donor) b heme Reference
QFR 348 to 355 320 to 379 3285 to 3320 350 to 370 MQb 374 absent [79,82^87]
SQR n.d.c +10 3175 +65 UQ +113 +36 [87,88]
Beef SQRa 379 0 3260 +60 UQ +113 3185 [87,89^92]
aData from beef heart SQR are included for comparison to the E. coli enzymes.
bMQ, menaquinone; UQ, ubiquinone.
cNot determined.
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3.3. Iron^sulfur protein (FrdB) of E. coli QFR
The FrdB subunit appears to be an example of a
modularly constructed iron^sulfur protein. In agree-
ment with sequence [49,63] and electron paramag-
netic resonance (EPR) analysis [1,2,79^81] the FrdB
subunit is organized into two domains. The N-termi-
nal domain (FrdB residues 1^91) contains the [2Fe^
2S] cluster and has a fold similar to plant-type fer-
redoxins [52]. The C-terminal domain of the subunit
(FrdB residues 145^221) exhibits a fold reminiscent
to that of bacterial ferredoxins and contains cysteine
ligands for the [4Fe^4S] and [3Fe^4S] clusters of the
enzyme. The iron^sulfur clusters are arranged in a
linear chain and their close physical organization
(edge-to-edge distances less than V12 Aî ) suggests
they all participate in electron transfer between the
quinol pool and the £avin at the active site
[20,52,60]. This had been an area of controversy
for a number of years as the low potential of the
[4Fe^4S] cluster (Table 1) had led to speculation
that this cluster did not participate directly in elec-
tron transfer [2,79]. The low potential of the [4Fe^4S]
cluster is not, however, a thermodynamic barrier to
electron transfer in E. coli QFR because of the close
spatial proximity as detailed by others [20,93]. The
structure and theoretical calculations are also consis-
tent with observation that catalytic electron transfer
in FrdAB involves the [4Fe^4S] cluster. Protein ¢lm
voltammetry has shown that at higher pH and ele-
vated fumarate levels the [4Fe^4S] cluster makes an
important contribution to catalytic electron transfer
in E. coli FrdAB [94].
The arrangement of the iron^sulfur clusters in
SQR are undoubtedly the same as that found for
QFR as the iron^sulfur protein subunits have a
high degree of sequence similarity including the ar-
rangement of the cysteine residues. The E. coli SdhB
subunit does have one anomaly with respect to the
arrangement of cysteine residues for the [2Fe^2S]
cluster. The third cysteine in SdhB is replaced by
an aspartate residue (CxxxxCxxDTC) [63], however,
it was shown that replacing the third cysteine in the
equivalent E. coli FrdB sequence with an aspartate
allowed retention of the [2Fe^2S] cluster although
with a slightly higher redox potential [95]. The mu-
tant QFR enzyme retained normal catalytic activity
and supports the interpretation that aspartate is a
normal ligand for the [2Fe^2S] cluster in E. coli
SQR.
3.4. Catalytic activity of fumarate reductase and
succinate dehydrogenase
The soluble catalytic domain of fumarate reduc-
tase (FrdAB) and succinate dehydrogenase (SdhAB)
as described above are often used to characterize
enzymatic activity of the enzymes. In fact many of
the early studies with the E. coli enzymes used par-
tially puri¢ed protein which consisted of only the
soluble domain of the enzymes [10,12]. Studies of
fumarate reduction by membrane-bound SQR and
QFR using the benzylviologen radical as electron
donor have revealed two types of kinetic behavior
[23]. E. coli QFR demonstrates simple kinetic behav-
ior in that the rate of the reaction is decreased as the
donor is oxidized during the reaction. By contrast E.
coli SQR, and all enzymes classi¢ed as SQRs [23],
show a negative order kinetics in that the rate of
the reaction increases as the concentration of the
electron donor benzylviologen decreases during the
reaction. This phenomenon has been elegantly
studied using protein ¢lm voltammetry with the solu-
ble forms FrdAB and SdhAB absorbed on to a
graphite electrode [94,96,97]. In the case of soluble
E. coli FrdAB the rate of electron transfer between
the electrode and succinate/fumarate is a function of
electrode potential (driving force) and the resulting
current is proportional to the rate of succinate oxi-
dation (higher potential) or fumarate reduction (low
potential) [94]. By contrast, soluble succinate dehy-
drogenase from either E. coli (SdhAB) or beef heart
demonstrates the e¡ect which has been termed the
‘diode e¡ect’, i.e., a sharp drop in catalytic activity
when the critical redox potential of lower than 385
mV is exceeded [96,97]. It was proposed, therefore,
that the reduction of FAD at the active site could
alter the rate of catalysis and function as a switch
that shuts down fumarate reduction at low poten-
tials. These studies further show that E. coli SdhAB
in addition to functioning as a succinate dehydroge-
nase can also function as an excellent fumarate re-
ductase, however, its activity in the latter direction is
limited to narrow range of redox potential [97].
These results are consistent with in vivo studies
showing that E. coli SQR can function as a fumarate
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reductase if allowed to express [19]. The electrochem-
ical assay used in the study of SdhAB/FrdAB seems
to be a powerful tool to investigate redox enzymes.
Non-catalytic voltammetry allows one to identify re-
dox centers of the enzymes and determine their ther-
modynamic properties [94,96^98]; and the electrical
current during steady-state catalysis correlate very
well with data obtained by traditional kinetic meth-
ods [99].
In addition, to the elegant use of protein ¢lm vol-
tammetry to measure catalytic activity the most com-
mon spectrophotometric method used for determin-
ing the succinate dehydrogenase activity of the
soluble enzyme forms, as well as for SQR and
QFR, is to use phenazine ethosulfate as primary elec-
tron acceptor coupled to the reduction of 2,6-dichlor-
ophenolindophenol ([2] and references therein,
[100,101]). In the case of E. coli QFR the succinate
dehydrogenase activity can me measured by the for-
mer method or the same turnover number is found
with K3Fe(CN)6. The ferricyanide reductase activity
of QFR is catalyzed equally well by the enzyme in
the membrane, as an isolated four-subunit complex,
and by the soluble FrdAB domain. This is di¡erent
than that found for soluble bovine heart succinate
dehydrogenase where both a high and low Km ferri-
cyanide reductase activity is observed [2,102] or for
E. coli SQR whose properties are like the mamma-
lian enzyme [100]. The presence of the ferricyanide
reductase activity in E. coli QFR indicates that one
of the redox centers is more exposed to solvent and
directly able to reduce the acceptor as compared to
SQR where this redox center is not apparently acces-
sible. The most likely redox center is the [3Fe^4S]
cluster based on studies with bovine heart succinate
dehydrogenase [2,102]. These data would also predict
that the [3Fe^4S] cluster in succinate dehydrogenase
is in a more hydrophobic (thus impermeant to
Fe(CN)6) environment than the same cluster in E.
coli fumarate reductase.
3.5. Transmembrane anchor domain of E. coli QFR
and SQR
The transmembrane domain of E. coli SQR and
QFR each encompasses two hydrophobic subunits
(SdhC/FrdC and SdhD/FrdD) with each subunit
having three transmembrane helices connected by ex-
tra-membrane loops [4,22,52]. As shown from the
structure of E. coli QFR [25], and anticipated from
models of the hydrophobic domain of SQR [4,22],
the amino-terminus is on the cytoplasmic side of
the membrane and the carboxy-terminus of each sub-
unit is located on the periplasmic side of the mem-
brane. A major di¡erence between E. coli SQR and
QFR is the composition of the redox cofactors
present in the membrane-spanning domain. E. coli
SQR and QFR operate in an environment where
both ubiquinone and menaquinone are present. E.
coli QFR when expressed under aerobic growth con-
ditions e¡ectively supports aerobic respiration [103].
In a similar fashion, if SQR is expressed under an-
oxic conditions, the SQR complex is able to support
a low rate of cell growth by operating as a menaqui-
nol-fumarate reductase [19]. Thus, in vivo both en-
zymes can complement each other if the organism is
genetically manipulated to express only one or the
other. As shown in the structure for QFR [52] (Fig.
1) two menaquinone molecules are present and these
are located on opposite sides of the membrane. The
presence of menaquinone is consistent with the an-
aerobic expression of QFR which is the predominant
quinone synthesized by E. coli under anoxic condi-
tions [104].
SQR, in addition to di¡erences in the type of qui-
none it uses as compared to QFR, is known to con-
tain a single b556 heme moiety placing it in the type I
class of complex IIs [4]. The heme in E. coli SQR has
been shown to have bis-histidine axial ligation [105],
as is the case for the heme(s) for other SQR and
QFR complexes that have been studied [53,106,
107]. It is known that the heme in SQR is important
for proper assembly of complex II. It was ¢rst shown
in B. subtilis SQR that di-heme-de¢cient mutants ac-
cumulate the £avoprotein and iron^sulfur protein
catalytic domain subunits in the cytoplasm [107].
Similar results have been reported for the single b
heme containing E. coli SQR [108]. As predicted
by models for the membrane anchors of SQR [22]
the axial ligands for the heme in E. coli SQR bridge
between the SdhC and SdhD subunits. This was
con¢rmed by site-directed mutagenesis studies
where His84 of SdhC and His71 of SdhD were
shown to be the heme ligands in the E. coli enzyme
[65,66]. As evidenced by sequence alignments of
the E. coli SQR and QFR membrane domain sub-
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units [4]ahistidyl residue equivalent to His71 is lack-
ing in FrdD. This may be one reason this QFR com-
plex lacks heme although the packing of the trans-
membrane helices also might preclude the ligation of
the heme.
3.6. Activity of QFR and SQR with quinones
The succinate quinone reductase and menaquinol
fumarate oxidase reactions of puri¢ed E. coli SQR
and QFR may be assayed with analogues of ubiqui-
none and menaquinone as has been described in the
references noted [100,109]. The large variety of do-
nors/acceptors used by di¡erent workers complicates
a direct comparison of the activity of the enzymes
under similar conditions. Therefore, in Table 2 are
shown kinetic parameters for E. coli SQR and QFR
assayed under the same conditions and for compara-
tive purposes data is shown for bovine SQR
[110,111] where the same assays have been used
(although at 38‡C vs. 30‡C for the E. coli enzymes).
The e⁄ciencies of the enzymes as a functional succi-
nate-quinone reductase or quinol-fumarate oxidase
depends on the type of quinone used for assay.
QFR is very potent in fumarate reduction while op-
erating with menaquinol, however, ubiquinol-fuma-
rate reductase activity was not detected. QFR does
function well as a succinate-quinone reductase with
the ubiquinone analogue Q2. Similar results are seen
with SQR where with ubiquinone/ubiquinol the en-
zyme is pro¢cient in succinate oxidation and interac-
tion with menaquinone/menaquinol transforms the
enzyme into a fumarate reductase. E. coli SQR and
QFR show similar Km values with more hydrophobic
quinone analogues such as Q2/QH2 and MQ1/
MQ1H2. Using more soluble quinone analogues,
however, does reveal signi¢cant di¡erences in the af-
¢nity of SQR and QFR for quinones. SQR seems
indi¡erent to the number of isoprenoid groups at-
tached to quinone head group, while QFR shows
more than a one order of magnitude lower a⁄nity
for the soluble quinone analogues (Q1 and 2,3-di-
methyl-1,4-naphthoquinone) [100], lapachol (Km =
85 WM) and plumbagin (Km = 155 WM) for fumarate
reduction [109].
Comparison of di¡erent quinone site inhibitors
reveals common inhibitors and those speci¢c for
only QFR or mammalian enzymes. Pentachlorophe-
nol (PCP) [100] and a series of 2-alkyl-4,6-dinitro-
phenols are potent inhibitors of both E. coli enzymes
as well as mammalian SQR [112] (Table 2). For ex-
ample, 5,6-dihydro-2-methyl-1,4-oxathiin-3-carbox-
anilide (carboxin), which for many years has been
known as a potent inhibitor of mammalian SQR
([2] and references therein), and Paracoccus denitri¢-
cans SQR [113] has a one order magnitude higher Ki
in E. coli SQR than it does in mammalian SQR; and
carboxin does not inhibit E. coli QFR even at mM
levels (Table 2). 4,4,4-Tri£uoro-1-(2-thienyl)-butane-
1,3-dione (TTFA) another strong and often used
inhibitor for mammalian SQR, thought to inhibit
at a binding site similar to the carboxin site, does
not inhibit either E. coli SQR or QFR. By contrast,
2-n-heptyl-4-hydroxyquinoline N-oxide (HQNO) is
Table 2
Kinetic parameters of the succinate-quinone and quinol-fumarate reductase reactions of SQR and QFRa
Succinate oxidation Fumarate reduction
E. coli QFRb E. coli SQRb Bovine heart SQRc E. coli QFRb E. coli SQRb Bovine heart SQRc
Reaction with Q2/Q2H2
kcat (s31) 28 85 111 1.7 2.7
Km (WM) 1.3 2 0.3 5 1.5
Reactions with MQ1/MQ1H2
kcat (s31) 14 177 3.4
Km (WM) 1.5 5.4 3
KPCPi (WM) 23 13 37 17 1
Kcarboxini (WM) 30 2 35 3
KHQNOi (WM) 0.075 0.2
aTurnover number is de¢ned as mol substrate reduced/oxidized per s per mol of enzyme.
bpH 7.8, 30‡C (data from [100]).
cpH 7.8, 38‡C (data from [110]) ; turnover number calculated based on 6 nmol FAD mg31.
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a very potent inhibitor of E. coli QFR, but E. coli
and mammalian SQR are not sensitive to this
inhibitor. The fact that the structure of HQNO
resembles a semi(naphtho)quinone and thus mena-
quinone more than ubiquinone may be signi¢cant
in this regard. The di¡erences in sensitivity to the
di¡erent inhibitors is not surprising in agreement
with the poor degree of sequence similarity of the
membrane anchoring subunits of complex II. It
has been shown that single amino acid substitutions
can have major e¡ects on the sensitivity of complex
II to quinone site inhibitors [113,114]. Subtle changes
in the site where quinones interact can thus have
major e¡ects on the binding of quinone site inhibi-
tors.
3.7. Activity of enzymes as a function of pH
A similar pH pro¢le in assays of succinate-quinone
reductase and quinol-fumarate reductase activities
has also been shown for E. coli QFR and SQR
[100]. The similarity of pH pro¢les exhibited by the
two enzymes suggests that similar amino acid resi-
dues may be involved in quinol deprotonation and
oxidation in the E. coli enzymes. The pH pro¢le ob-
served for quinone reactions of the two bacterial en-
zymes is similar to bovine SQR where it was sug-
gested that ionization of a group with a pKa near
7.0 was important for enzyme activity. By contrast,
a mirror-image pH pro¢le was observed for bovine
SQR succino-oxidase and fumarate reductase activ-
ities and it was suggested that the imidazole moiety
of a histidyl residue was responsible [115]. A con-
served histidyl residue near the dicarboxylate binding
site of E. coli QFR was subsequently shown to be
important for catalytic activity in support of the pre-
vious observations [116]. The availability of struc-
tures of both membrane-bound and soluble fumarate
reductases has greatly expanded our knowledge of
the detailed mechanism of catalysis at the dicarbox-
ylate binding site. Detailed kinetic and crystallo-
graphic studies support a common mechanism for
fumarate reduction and show the importance of con-
served arginine and histidine residues at the active
site of this class of enzymes [117,118]. The reader is
referred to these excellent articles for a complete de-
scription of the proposed mechanism for fumarate
reduction.
Fig. 2. Quinone binding sites in E. coli QFR. The QP binding pocket is shown on the left of the ¢gure. The QP menaquinone (shown
in blue) is in a relatively polar pocket surrounded by amino acid residues from the FrdB (pink), FrdC (green), and FrdD (magenta)
subunits. The [3Fe^4S] cluster is shown as a space ¢lling model. The QP binding pocket suggests hydrogen bonds from the menaqui-
none to the sidechains of FrdB Lys228 and FrdC Glu29. The edge-to-edge distance from QP to the [3Fe^4S] cluster is 8.2 Aî . On the
right of the ¢gure is shown the binding pocket for menaquinone QD which is on the opposite side of the membrane from QP and the
two quinones are separated by 25 Aî . QD is situated in a relatively apolar pocket within the membrane bilayer. The amino acid side
chains are colored the same as for quinone QP.
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3.8. Binding sites for quinone in E. coli enzymes
Since a structure is now available for the E. coli
QFR complex we can for the ¢rst time obtain an
actual picture of the residues at the quinone binding
sites. In the E. coli QFR complex one of the mena-
quinone molecules (QP) is positioned proximal (8 Aî
distance) to the [3Fe^4S] cluster of the FrdB subunit
(Fig. 2) in a relatively polar pocket containing pro-
tonatable amino acid residues similar to the ex-
changeable QB site of the photosynthetic reaction
center [119]. Amino acids from the FrdB, FrdC,
and FrdD subunits appear to stabilize the quinone
at the QP site. At this site the menaquinone is within
hydrogen bonding distance of FrdC Glu29 and FrdB
Lys228. This lysine residue is conserved in the iron^
sulfur protein subunits of SQR and QFR. Approx-
imately 25 Aî away on the opposite side of the mem-
brane a second menaquinone (QD) distal to the [3Fe^
4S] cluster resides (Fig. 2). QD on the periplasmic
side of the membrane is found in a hydrophobic
pocket that resembles the QA site of photosynthetic
reaction centers.
The E. coli QFR system has allowed the direct
detection of a very fast relaxing semiquinone free
radical species (P1=2E500 mW) which shows spatial
proximity to the [3Fe^4S] cluster similar to the semi-
quinone species found in beef heart SQR [120]. This
was accomplished by EPR analysis of an FrdC
Glu29 to Leu substitution which gives a much
more intense semiquinone EPR spectrum because
of the enhanced stability of the semiquinone
(Kstab = 1.2U1032 at pH 7.2, some four orders of
magnitude more stable than the semiquinone in
wild-type QFR [120]). It is apparent in wild-type
QFR that Glu29 destabilizes the anionic semiqui-
none at the QP site as compared to the Leu substi-
tution. Previous to these studies with the mutant
forms of QFR it had not been possible to directly
detect stabilized semiquinones associated with com-
plex II in bacteria. It has also been shown that qui-
none binding site inhibitors such as carboxin and
TTFA perturb a quinone binding site in bovine
SQR which is proximal to the [3Fe^4S] cluster
[121^123]. HQNO has a Ki in the nM range for qui-
none reactions with E. coli QFR [94,124,125] and B.
subtilis SQR [126]. The location of the binding site
for HQNO in E. coli QFR is clearly near the QP site
based on inhibition properties and perturbation of
the EPR signal of the [3Fe^4S] cluster [127]. In the
Fig. 3. Electron pathways in E. coli QFR (a, b) and SQR (c). Scheme (a) represents the electron pathways from succinate/fumarate to
menaquinone/menaquinol through FAD, the three iron^sulfur centers to a single quinone exchangeable QP site. In scheme (b) an addi-
tional redox mediator (?) is suggested to mediate the electron transfer between the QP site and the hydrophobic non-exchangeable QD
site (dashed arrows). In scheme (c) E. coli SQR accepts the single QP site electrons directly from the [3Fe^4S] center. The dashed ar-
row shows the fast electron exchange between the QP site and heme b556. The presence of a QD site in SQR is as yet unknown and
marked with a (?).
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case of E. coli QFR the 25 Aî distance between QP
and QD suggests that these quinones are not the
interacting anionic semiquinone pair seen in the
mammalian enzyme. Thus, the simplest mechanism
for quinone-reduction involves a single quinone QP
where electron transfer between the [3Fe^4S] cluster
and quinone occurs. In such a model the quinone
found at QD would play a structural role rather
than participate in electron transport in E. coli
QFR (Fig. 3a).
The existence of two quinone binding sites has
been suggested by site-directed mutagenesis studies
of E. coli QFR [128], S. cerevisiae SQR [129,130]
and by photoa⁄nity labeling studies of mitochon-
drial and E. coli SQR [131,132]. The large distance
between QP and QD would seem to preclude direct
electron transfer between the two quinones as dis-
cussed above and by Dutton and co-workers
[20,93]. Nevertheless for many years it has been
known in mammalian SQR that a stabilized semi-
quinone pair exists in mammalian complex II [133].
EPR simulations suggested that the interacting semi-
quinone pair were some 8 Aî apart [133] and that the
quinone rings were oriented perpendicular to the
membrane plane [134]. The stability constant for
the ubisemiquinone radical was found to be 10 which
is many orders of magnitude greater than for un-
bound radical (10310) [121]. Spin-coupled Q3Q3
split signals as seen in mammalian complex II were,
however, not detected in E. coli QFR. EPR signals
from an interacting semiquinone pair are much more
sensitive to perturbation than those from a single
semiquinone and thus it can be very di⁄cult to ob-
serve spin-coupled semiquinones [121]. As indicated
above in E. coli QFR only a single stabilized anionic
semiquinone species is observed rather than an inter-
acting pair. Thus if both QP and QD are involved in
electron transfer reactions and additional redox ac-
tive cofactor must intervene between the two qui-
nones because of their large spatial separation. As
diagrammed in Fig. 3b such a factor (?) could close
the gap between the two quinones. The additional
redox active cofactor could be another quinone
which is not represented in the structure and not
detected by EPR or another redox active factor
which is not seen in the X-ray structure. As indicated
above a stabilized semiquinone pair is often very
di⁄cult to detect and thus its presence cannot be
ruled out.
It is well established that heme b556 in E. coli SQR
is important for enzyme assembly [66,108]. Earlier
suggestions that His71 of SdhD is one of the axial
ligands of the heme [65] have been recently con¢rmed
[66]. These later studies, however, show that substi-
tution of His84 by Leu in SdhC result in retention of
low-spin heme which became reactive with carbon
monoxide when the enzyme was reduced [66]. As
SdhC His84 is considered the other axial ligand to
the heme [65] these results were interpreted as indi-
cating that another histidyl residue in the membrane
domain of SQR could substitute for SdhC His84 in
the mutant enzyme [66]. Further studies of additional
amino acid substitutions at SdhC His84 have shown
that a high-spin heme is formed con¢rming the orig-
inal interpretation that SdhC His84 is indeed the
second axial ligand for heme b556 in E. coli SQR
(E. Makalshina, R.A. Rothery, J.H. Weiner, G. Cec-
chini, in preparation). It was also shown that the
quinone site inhibitor PCP perturbs the heme optical
spectrum of wild-type E. coli SQR but not that of an
SdhC His84Leu mutant enzyme [66]. There was as
well a signi¢cant increase in the Km and a decrease in
the kcat for ubiquinone-1 in the mutant enzyme.
These results suggest that SdhC His84 may be part
of a Q binding pocket or that the loss of the heme
axial ligand signi¢cantly e¡ect the conformation of
the anchoring domain. In E. coli SQR azidoquinones
have been used to label the SdhC subunit and have
implicated Ser27 and Arg31 as being part of a qui-
none binding site in the enzyme [135]. Thus, SdhC
His84 would be part of a quinone binding pocket
along with Ser27 and Arg31 (Fig. 3c). The results
also agree with available structures and models for
the transmembrane domain of complex II [4,22,
52,53]. As SdhC His84 is normally one of the axial
ligands for the b heme of E. coli SQR [65] the re-
sults further suggest that this binding site for qui-
none is similar to QP of E. coli QFR, except the b
heme is located nearby in E. coli SQR. In alignments
of the C-subunits of complex II [4] FrdC His82 and
SdhC His84 are in conserved positions. In QFR
FrdC His82 is approximately 7^9 Aî from QP which
may supports the location of SdhC His84 as being
near a quinone binding site. Therefore, in E. coli
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SQR like QFR a QP site is located near the [3Fe^4S]
cluster from the iron^sulfur protein subunit on the
cytoplasmic side of the membrane.
There is no high resolution structural information
yet available for E. coli SQR. Nevertheless, the struc-
tural information available for E. coli QFR shows
that the QP site is nearer the [3Fe^4S] cluster (9 Aî )
than is the heme of W. succinogenes QFR to that
[3Fe^4S] cluster (17 Aî ). Heme b556 in E. coli SQR
is completely reducible by succinate under anaerobic
conditions with a rate of about two orders of mag-
nitude slower than the turnover number of the en-
zyme [143], however, the heme is in fast equilibrium
with UQ/UQH2. The simplest mechanism of quinone
reduction in E. coli SQR would thus be direct reduc-
tion of quinone via the [3Fe^4S] cluster in a site like
QP. Here heme b556 would not be an obligatory com-
ponent of the electron transfer pathway. It should be
noted than in B. subtilis SQR it has been reported
that the high potential heme is reducible by succinate
with the same rate as the turnover of the enzyme
[136] indicating that this heme does participate di-
rectly in electron transfer. The simple Michaelis^
Menten kinetics for quinone reduction/quinol oxida-
tion seen in E. coli SQR support the hypothesis of a
single quinone binding site being involved in the cat-
alytic mechanism [100].
In B. subtilis SQR, HQNO induces a shift in the
spectrum and Em of heme bD indicating that the in-
hibitor binds on the distal (outside) side of the mem-
brane in that organism. Thus, it has been speculated
that HQNO binds to topographically di¡erent, but
functionally similar sites in E. coli QFR and B. sub-
tilis SQR [120]. This is also in agreement with obser-
vations from W. succinogenes where the site for me-
naquinol oxidation is found near heme bD on the
outside of the membrane and where a glutamate res-
idue has also been shown to be important in reaction
with quinones [137]. Since the structural determina-
tion of E. coli QFR shows density for only the two
menaquinone molecules [52] it has been hypothesized
that a third redox active cofactor may exist to medi-
ate electron transfer between QP and QD if in fact
both quinones participate in catalysis [20,60]. For E.
coli SQR the intervening cofactor could be the b
heme moiety (Fig. 3c). There is no evidence to sug-
gest that either E. coli SQR or QFR is involved in
the generation of transmembrane vWH [20,53] and
the role of the hydrophobic QD binding site seen in
E. coli QFR [52] thus remains enigmatic. That a
menaquinone molecule is part of the electron trans-
port chain on the periplasmic face of W. succinogenes
QFR has recently been established by site-directed
mutagenesis studies [137] of that enzyme and is in
agreement with proton-transfer models for that en-
zyme [20,53] although proton translocation by that
enzyme has yet to be unequivocally established. As
evidenced by the di¡erent proposed classi¢cations
schemes for QFR and SQR [4,20] the E. coli enzymes
may retain structural evolutionary features [24] but
no longer have the ability to couple electron transfer
to the production of a transmembrane vWH .
3.9. Reactivity of E. coli QFR and SQR with oxygen
If in E. coli, SQR and QFR can functionally re-
place each other the question remains as to why the
organism has evolved two enzymes. A possible an-
swer may involve one of the signi¢cant di¡erences
between the two enzymes. E. coli QFR can rapidly
generate superoxide anion upon reduction of the en-
zyme by succinate [138]. Superoxide production by
E. coli QFR is some two orders of magnitude greater
than that produced by E. coli SQR. The production
of superoxide is not sensitive to quinone site inhib-
itors and apparently the reaction of FAD with oxy-
gen is responsible for the high levels of production of
superoxide. The maximum rate for superoxide pro-
duction is found at low (about Ksuccm ) concentrations
of succinate and higher concentrations of succinate
inhibit superoxide production by QFR. The degree
of reduction of QFR, or conformational changes
upon occupation of the dicarboxylate binding site
of QFR, may be responsible for controlling the
rate of generation of superoxide anion. Since QFR
normally operates in an anaerobic environment pro-
duction of superoxide would not normally be a prob-
lem for the cell [138], however, if it was normally
expressed aerobically the large amount of superoxide
might prove toxic to E. coli. It would be of interest
to know if B. subtilis SQR also generates high levels
of superoxide like E. coli QFR. B. subtilis SQR op-
erates in an aerobic environment with menaquinone
and does not show the diode e¡ect [23] similarly to
E. coli QFR even though operationally it is a succi-
nate dehydrogenase.
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4. Perspective on complex II
Our understanding of the structure and function of
complex II has advanced signi¢cantly in the past
several years particularly because of the availability
of three dimensional structures of fumarate reduc-
tases. A more general picture will emerge when we
also obtain structures for SQR which can be antici-
pated in the near future. Although QFR and SQR
are highly similar some fascinating di¡erences in
their catalytic behavior make them intriguing models
for study of redox enzymes. An advantage of E. coli
for study of complex II is that one can readily inves-
tigate the biochemistry and physiology of the en-
zymes in their native environment and the organism
allows a wealth of experimental manipulations. Re-
cently mutations in nuclear genes encoding complex
II subunits have been associated with a myopathy
[139], oxidative stress and more rapid aging [140],
and paraganglioma [141,142]. The structures now
available suggest that these mutations causing para-
ganglioma syndrome and more rapid aging are af-
fecting the heme and quinone binding domains of
complex II. Understanding the function of these re-
dox active cofactors in complex II and how altera-
tions in the environment where they work should
give us a more complete knowledge of the physiolog-
ical role of complex II in various disease states. The
QFR structures and the high degree of similarity of
E. coli SQR to its mammalian counterparts will al-
low experimentalists to manipulate the E. coli en-
zymes to provide insights into the function of com-
plex II in mammals. Thus 75 years after the ¢rst
observation of an equilibrium between succinic and
fumaric acids in E. coli [5] complex II from this or-
ganism continues to be an excellent model for our
understanding of this fascinating membrane-bound
protein complex.
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